Tirzepatide superior to intensified conventional care for early type 2 diabetes
MedicalXpress
|
mai 27, 2026
Tirzepatide is superior to intensified conventional care (ICC) for adults with early type 2 diabetes (T2D) uncontrolled with metformin, according to a study published online May 26 in the Annals of Internal Medicine.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗